These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9095250)

  • 1. Characterisation of recombinant isoforms of birch pollen allergen Bet v 1.
    Spangfort MD; Ipsen H; Sparholt SH; Aasmul-Olsen S; Osmark P; Poulsen FM; Larsen M; Mørtz E; Roepstorff P; Larsen JN
    Adv Exp Med Biol; 1996; 409():251-4. PubMed ID: 9095250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning and characterization of a birch pollen minor allergen, Bet v 5, belonging to a family of isoflavone reductase-related proteins.
    Karamloo F; Schmitz N; Scheurer S; Foetisch K; Hoffmann A; Haustein D; Vieths S
    J Allergy Clin Immunol; 1999 Nov; 104(5):991-9. PubMed ID: 10550744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations.
    Niederberger V; Pauli G; Grönlund H; Fröschl R; Rumpold H; Kraft D; Valenta R; Spitzauer S
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):579-91. PubMed ID: 9802365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.
    Ferreira F; Hirtenlehner K; Jilek A; Godnik-Cvar J; Breiteneder H; Grimm R; Hoffmann-Sommergruber K; Scheiner O; Kraft D; Breitenbach M; Rheinberger HJ; Ebner C
    J Exp Med; 1996 Feb; 183(2):599-609. PubMed ID: 8627171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy.
    Batard T; Didierlaurent A; Chabre H; Mothes N; Bussières L; Bohle B; Couret MN; Ball T; Lemoine P; Focks Tejkl M; Chenal A; Clément G; Dupont F; Valent P; Krauth MT; André C; Valenta R; Moingeon P
    Int Arch Allergy Immunol; 2005 Mar; 136(3):239-49. PubMed ID: 15722633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season.
    van Hage-Hamsten M; Kronqvist M; Zetterström O; Johansson E; Niederberger V; Vrtala S; Grönlund H; Grönneberg R; Valenta R
    J Allergy Clin Immunol; 1999 Nov; 104(5):969-77. PubMed ID: 10550741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Bet v 1 isoforms including a naturally occurring truncated form of the protein derived from Austrian birch pollen.
    Friedl-Hajek R; Radauer C; O'Riordain G; Hoffmann-Sommergruber K; Leberl K; Scheiner O; Breiteneder H
    Mol Immunol; 1999 Jul; 36(10):639-45. PubMed ID: 10509815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid production of the major birch pollen allergen Bet v 1 in Nicotiana benthamiana plants and its immunological in vitro and in vivo characterization.
    Krebitz M; Wiedermann U; Essl D; Steinkellner H; Wagner B; Turpen TH; Ebner C; Scheiner O; Breiteneder H
    FASEB J; 2000 Jul; 14(10):1279-88. PubMed ID: 10877820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
    Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
    J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four recombinant isoforms of Cor a I, the major allergen of hazel pollen, show different IgE-binding properties.
    Breiteneder H; Ferreira F; Hoffmann-Sommergruber K; Ebner C; Breitenbach M; Rumpold H; Kraft D; Scheiner O
    Eur J Biochem; 1993 Mar; 212(2):355-62. PubMed ID: 7916686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and immunological importance of Bet v 1 isoforms.
    Breitenbach M; Ferreira F; Jilek A; Swoboda I; Ebner C; Hoffmann-Sommergruber K; Briza P; Scheiner O; Kraft D
    Adv Exp Med Biol; 1996; 409():117-26. PubMed ID: 9095231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced in vivo allergenicity of Bet v 1d isoform, a natural component of birch pollen.
    Arquint O; Helbling A; Crameri R; Ferreira F; Breitenbach M; Pichler WJ
    J Allergy Clin Immunol; 1999 Dec; 104(6):1239-43. PubMed ID: 10589007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of recombinant Bet v I, the major birch pollen allergen. Immunological equivalence to natural Bet v I.
    Ferreira FD; Hoffmann-Sommergruber K; Breiteneder H; Pettenburger K; Ebner C; Sommergruber W; Steiner R; Bohle B; Sperr WR; Valent P
    J Biol Chem; 1993 Sep; 268(26):19574-80. PubMed ID: 8366100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of an 18-kd allergen of birch (Betula verrucosa) pollen: identification as a cyclophilin.
    Cadot P; Diaz JF; Proost P; Van Damme J; Engelborghs Y; Stevens EA; Ceuppens JL
    J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):286-91. PubMed ID: 10669849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-level expression and purification of the major birch pollen allergen, Bet v 1.
    Hoffmann-Sommergruber K; Susani M; Ferreira F; Jertschin P; Ahorn H; Steiner R; Kraft D; Scheiner O; Breiteneder H
    Protein Expr Purif; 1997 Feb; 9(1):33-9. PubMed ID: 9116499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominating IgE-binding epitope of Bet v 1, the major allergen of birch pollen, characterized by X-ray crystallography and site-directed mutagenesis.
    Spangfort MD; Mirza O; Ipsen H; Van Neerven RJ; Gajhede M; Larsen JN
    J Immunol; 2003 Sep; 171(6):3084-90. PubMed ID: 12960334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of specific IgE antibodies in sera of Japanese birch-allergic patients using recombinant allergens Bet v 1, Bet v 2 and Bet v 4.
    Shirasaki H; Yamamoto T; Koyanagi Y; Watanabe N; Himi T
    Allergol Int; 2008 Mar; 57(1):93-6. PubMed ID: 18209509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization, expression in Escherichia coli, and epitope analysis of a two EF-hand calcium-binding birch pollen allergen, Bet v 4.
    Twardosz A; Hayek B; Seiberler S; Vangelista L; Elfman L; Grönlund H; Kraft D; Valenta R
    Biochem Biophys Res Commun; 1997 Oct; 239(1):197-204. PubMed ID: 9345295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of purified recombinant Bet v 1 with authentic N-terminus, cloned in fusion with maltose-binding protein.
    Spangfort MD; Ipsen H; Sparholt SH; Aasmul-Olsen S; Larsen MR; Mørtz E; Roepstorff P; Larsen JN
    Protein Expr Purif; 1996 Nov; 8(3):365-73. PubMed ID: 8936599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization.
    Movérare R; Westritschnig K; Svensson M; Hayek B; Bende M; Pauli G; Sorva R; Haahtela T; Valenta R; Elfman L
    Int Arch Allergy Immunol; 2002 Aug; 128(4):325-35. PubMed ID: 12218371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.